MedTrace Logo

Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

NCT05170113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2022-07-28

No results posted yet for this study

Summary

The purpose of this study is to assess the effectiveness and safety of the Alpinia galanga formulation, Theacrine formulation, and Caffeine formulation on fatigue, mental acuity, and cognitive health among overall healthy participants

Conditions

Interventions

DIETARY_SUPPLEMENT

Alpinia galanga formulation

Alpinia galanga formulation capsule- 1 capsule daily

DIETARY_SUPPLEMENT

Theacrine formulation

Theacrine formulation capsule- 1 capsule daily

DIETARY_SUPPLEMENT

Caffeine formulation

Caffeine formulation capsule- I capsule daily

DIETARY_SUPPLEMENT

Placebo

Placebo capsule- 1 capsule daily

Sponsors & Collaborators

  • Supplement Formulators, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Swick, PhD · Life Extension

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-02
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05170113 on ClinicalTrials.gov